TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07337525: A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

Sponsor: Pilatus Biosciences Inc · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 36 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$376,992

Rescue Site Savings

+$251,328

Unlock Full NCT07337525 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07337525 Rescue Dossier →